Creo Medical Group PLC Working Capital to Net Assets Ratio
Creo Medical Group PLC working capital to net assets ratio. Creo Medical Group PLC (CREO) has a Working Capital to Net Assets ratio of 32.4% as of December 2025. Working capital of GBX16.20 Million (current assets of GBX23.50 Million minus current liabilities of GBX7.30 Million) is measured against net assets of GBX50.00 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Creo Medical Group PLC (CREO) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Creo Medical Group PLC (2014–2025)
Working capital to net assets ratio of Creo Medical Group PLC from 2014 to 2025. This chart shows how Creo Medical Group PLC's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2014 to 2025. As of December 2025, the ratio stands at 32.4%, reflecting working capital of GBX16.20 Million against net assets of GBX50.00 Million GBX. See defensive interval ratio of Creo Medical Group PLC to measure how many days the company can operate on defensive assets alone.
Creo Medical Group PLC Working Capital to Net Assets Ratio by Year (2014–2025)
Creo Medical Group PLC working capital to net assets ratio by year from 2014 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Creo Medical Group PLC from 2014 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Creo Medical Group PLC (CREO) total assets.
| Year | WC/NA Ratio | Working Capital (GBX) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 32.4% | GBX16.20 Million | GBX50.00 Million | GBX23.50 Million | GBX7.30 Million | ▼ -52.3 pp |
| 2024 | 84.7% | GBX35.90 Million | GBX42.40 Million | GBX56.40 Million | GBX20.50 Million | ▲ +37.8 pp |
| 2023 | 46.8% | GBX28.00 Million | GBX59.80 Million | GBX37.90 Million | GBX9.90 Million | ▲ +14.0 pp |
| 2022 | 32.8% | GBX16.20 Million | GBX49.40 Million | GBX33.69 Million | GBX17.48 Million | ▼ -23.7 pp |
| 2021 | 56.5% | GBX41.43 Million | GBX73.32 Million | GBX61.17 Million | GBX19.74 Million | ▼ -9.5 pp |
| 2020 | 66.0% | GBX41.44 Million | GBX62.81 Million | GBX59.47 Million | GBX18.03 Million | ▼ -32.0 pp |
| 2019 | 98.0% | GBX81.04 Million | GBX82.66 Million | GBX86.09 Million | GBX5.06 Million | ▼ -0.2 pp |
| 2018 | 98.2% | GBX46.87 Million | GBX47.71 Million | GBX48.51 Million | GBX1.64 Million | ▲ +4.5 pp |
| 2018 | 93.7% | GBX6.87 Million | GBX7.33 Million | GBX8.75 Million | GBX1.88 Million | ▼ -3.9 pp |
| 2017 | 97.6% | GBX14.30 Million | GBX14.65 Million | GBX15.77 Million | GBX1.47 Million | ▲ +13.5 pp |
| 2016 | 84.2% | GBX1.37 Million | GBX1.63 Million | GBX2.14 Million | GBX773.77K | ▼ -9.8 pp |
| 2016 | 94.0% | GBX3.03 Million | GBX3.22 Million | GBX3.54 Million | GBX512.38K | ▲ +10.8 pp |
| 2015 | 83.2% | GBX622.38K | GBX748.41K | GBX918.37K | GBX295.98K | ▼ -6.7 pp |
| 2014 | 89.9% | GBX1.24 Million | GBX1.37 Million | GBX1.49 Million | GBX250.20K | — |